Use of dapsone in chronic/refractory immune thrombocytopenic patients: A single center experience
Background: Dapsone is a second-line therapy for immune thrombocytopenia (ITP). It is cost-effective, with a response rate comparable to other drugs used as second-line therapy, such as azathioprine, danazol, cyclophosphamide, cyclosporine, vincristine, rituximab, and eltrombopag.Material and Method...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nizameddin KOCA
2023-04-01
|
| シリーズ: | Turkish Journal of Internal Medicine |
| オンライン･アクセス: | https://dergipark.org.tr/en/download/article-file/2800540 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|